ATE512366T1 - Ms-verfahren zur evaluierung von glycanen - Google Patents

Ms-verfahren zur evaluierung von glycanen

Info

Publication number
ATE512366T1
ATE512366T1 AT08745856T AT08745856T ATE512366T1 AT E512366 T1 ATE512366 T1 AT E512366T1 AT 08745856 T AT08745856 T AT 08745856T AT 08745856 T AT08745856 T AT 08745856T AT E512366 T1 ATE512366 T1 AT E512366T1
Authority
AT
Austria
Prior art keywords
glycans
evaluation
things
identification
mixture
Prior art date
Application number
AT08745856T
Other languages
English (en)
Inventor
Carlos Bosques
Nathaniel Washburn
Xiangping Zhu
Ian Parsons
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE512366T1 publication Critical patent/ATE512366T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT08745856T 2007-04-16 2008-04-15 Ms-verfahren zur evaluierung von glycanen ATE512366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92367707P 2007-04-16 2007-04-16
PCT/US2008/060334 WO2008128221A1 (en) 2007-04-16 2008-04-15 Ms methods to evaluate glycans

Publications (1)

Publication Number Publication Date
ATE512366T1 true ATE512366T1 (de) 2011-06-15

Family

ID=39615678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08745856T ATE512366T1 (de) 2007-04-16 2008-04-15 Ms-verfahren zur evaluierung von glycanen

Country Status (14)

Country Link
US (1) US8043863B2 (de)
EP (1) EP2135091B1 (de)
JP (1) JP5116837B2 (de)
AT (1) ATE512366T1 (de)
AU (1) AU2008240074B2 (de)
CA (1) CA2682750A1 (de)
CY (1) CY1111811T1 (de)
DK (1) DK2135091T3 (de)
ES (1) ES2367210T3 (de)
HR (1) HRP20110610T1 (de)
PL (1) PL2135091T3 (de)
PT (1) PT2135091E (de)
SI (1) SI2135091T1 (de)
WO (1) WO2008128221A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008240074B2 (en) 2007-04-16 2013-02-21 Momenta Pharmaceuticals, Inc. MS methods to evaluate glycans
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
EP2877589B1 (de) 2012-07-26 2024-03-06 Momenta Pharmaceuticals, Inc. Glykoproteine mit entzündungshemmenden eigenschaften
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP2991666B1 (de) 2013-05-02 2020-03-25 Momenta Pharmaceuticals, Inc. Sialylierte glycoproteine
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
EP3052640A2 (de) 2013-10-04 2016-08-10 AbbVie Inc. Verwendung von metallionen zur modulation von proteinglykosylierungsprofilen rekombinanter proteine
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP4310503A3 (de) 2015-12-30 2024-03-20 Momenta Pharmaceuticals, Inc. Verfahren im zusammenhang mit biologika
JP7571010B2 (ja) 2018-09-06 2024-10-22 モメンタ ファーマシューティカルズ インコーポレイテッド 連続細胞培養の方法
BR112021006852A2 (pt) 2018-10-11 2021-08-17 Momenta Pharmaceuticals, Inc. tratamento com composições de igg altamente sialilada
AU2019419372B2 (en) 2018-12-31 2026-03-26 Momenta Pharmaceuticals, Inc. Methods of producing ustekinumab

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3383587B2 (ja) 1998-07-07 2003-03-04 株式会社東芝 静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法
EP1518120A4 (de) * 2002-03-11 2008-08-13 Momenta Pharmaceuticals Inc Analyse sulfatierter polysaccharide
US20040147033A1 (en) * 2002-12-20 2004-07-29 Zachary Shriver Glycan markers for diagnosing and monitoring disease
WO2005009039A2 (en) * 2003-07-03 2005-01-27 Waters Investments Limited System and method for isotopic signature and mass analysis
US7138228B2 (en) 2003-09-05 2006-11-21 Regents Of The University Of California Protein O-sulfonation
US20060057638A1 (en) 2004-04-15 2006-03-16 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
EP1775581A4 (de) * 2004-08-04 2009-06-03 Eisai R&D Man Co Ltd Untersuchung einer ein peptid bildenden aminosäuresequenz in abhängigkeit vom isotopenverhältnis
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
WO2007025348A1 (en) * 2005-09-02 2007-03-08 Australian Nuclear Science & Technology Organisation An isotope ratio mass spectrometer and methods for determining isotope ratios
AU2008240074B2 (en) 2007-04-16 2013-02-21 Momenta Pharmaceuticals, Inc. MS methods to evaluate glycans

Also Published As

Publication number Publication date
CA2682750A1 (en) 2008-10-23
AU2008240074B2 (en) 2013-02-21
US20100133430A1 (en) 2010-06-03
US8043863B2 (en) 2011-10-25
PT2135091E (pt) 2011-09-01
AU2008240074A1 (en) 2008-10-23
EP2135091A1 (de) 2009-12-23
EP2135091B1 (de) 2011-06-08
HRP20110610T1 (hr) 2011-10-31
ES2367210T3 (es) 2011-10-31
PL2135091T3 (pl) 2011-11-30
SI2135091T1 (sl) 2011-10-28
JP5116837B2 (ja) 2013-01-09
DK2135091T3 (da) 2011-09-19
WO2008128221A1 (en) 2008-10-23
CY1111811T1 (el) 2015-10-07
JP2010525327A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
DK2135091T3 (da) MS-fremgangsmåder til evaluering af glykaner
EA201270350A1 (ru) Способ идентификации и получения (r)-специфической омега-трансаминазы
EA201500316A1 (ru) Антагонисты толл-подобного рецептора 3
UY32501A (es) Anticuerpo antagonista específico para el heterodímero alfa4-beta7
CL2009001263S1 (es) Maquina de afeitar.
PH12013502230A1 (en) Multispecific antibodies
WO2011047087A3 (en) Protein detection via nanoreporters
WO2012009644A3 (en) Methods to identify synthetic and natural rna elements that enhance protein translation
GB201014805D0 (en) Microfluidics based assay device
HK1214830A1 (zh) 新型ntrk1融合分子及其应用
CU24058B1 (es) Antagonistas de pcsk9
MX373121B (es) Composiciones y metodos para el tratamiento de leucemia.
BRPI0919186A2 (pt) aparelhos de barbear ou depilar e cartuchos.
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
GB2469962A (en) Automatic connections between application components
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
MX2019014654A (es) Agonistas de fgfr1 y sus metodos de uso.
WO2010111299A3 (en) Synthetic antibodies
IN2012DE01026A (de)
WO2016023991A8 (de) Verfahren zur mikrobiom-analyse
ATE532814T1 (de) Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
WO2012164525A3 (en) Aging biomarkers
ECSP11011190A (es) Anticuerpos monoclonales anti-rhd
MX2011011623A (es) Antagonistas del receptor tipo toll 3.
EA201290804A1 (ru) Способ активации и сопряжения биомолекул

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2135091

Country of ref document: EP